Open AccessLetter by Rozenbaum et al Regarding Article, “Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy”
Author(s) -
Mark H. Rozenbaum,
Jason E. Kemner,
Bhash Parasuraman
Publication year - 2020
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.120.046955
Subject(s) - medicine , orphan drug , transthyretin , cost effectiveness , bioinformatics , risk analysis (engineering) , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom